...
首页> 外文期刊>Journal of Clinical Microbiology >A Multiplex PCR Approach for Detecting Dual Infections and Recombinants Involving Major HIV Variants
【24h】

A Multiplex PCR Approach for Detecting Dual Infections and Recombinants Involving Major HIV Variants

机译:用于检测涉及主要HIV变异的双重感染和重组的多重PCR方法

获取原文
           

摘要

The cocirculation of different HIV types and groups can lead to dual infections and recombinants, which hinder diagnosis and therapeutic management. We designed two multiplex PCRs (mPCRs) coupled with capillary electrophoresis to facilitate the detection of such infections. The first, MMO2, targets three variants (HIV-1/M, HIV-1/O, and HIV-2), and the second, MMO, targets HIV-1/M and HIV-1/O. These mPCRs were validated on DNA and RNA extracts from 19 HIV-1/M, 12 HIV-1/O, and 13 HIV-2 cultures and from mixtures simulating dual infections. They were then assessed with DNA and RNA extracts from samples of 47 clinical monoinfections and HIV-1/M+O dual infections or infections with HIV-1/MO recombinants. Both mPCRs had excellent specificity. Sensitivities ranged from 80 to 100% for in vitro samples and from 58 to 100% for clinical samples, with the results obtained depending on the material used and the region of the genome concerned. Sensitivity was generally lower for DNA than for RNA and for amplifications of the integrase and matrix regions. In terms of global detection (at least one target gene for each strain), both mPCRs yielded a detection rate of 100% for in vitro samples. MMO2 detected 100% of the clinical strains from DNA and 97% from RNA, whereas MMO detected 100% of the strains from both materials. Thus, for in vitro and clinical samples, MMO2 was a useful tool for detecting dual infections with HIV-1 and HIV-2 (referred to as HIV-1+HIV-2) and HIV-1/M+O, and MMO was useful for detecting both MO dual infections and MO mosaic patterns.
机译:不同类型和类别的HIV的共同传播可导致双重感染和重组,从而阻碍诊断和治疗管理。我们设计了两个多重PCR(mPCR)与毛细管电泳相结合,以方便检测此类感染。第一个M MO2 靶向三种变体(HIV-1 / M,HIV-1 / O和HIV-2),第二个M MO 靶向HIV-1 / M和HIV-1 / O。这些mPCR已在19种HIV-1 / M,12种HIV-1 / O和13种HIV-2培养物以及模拟双重感染混合物的DNA和RNA提取物中进行了验证。然后用来自47种临床单感染和HIV-1 / M + O双重感染或HIV-1 / MO重组感染的样品的DNA和RNA提取物对它们进行评估。两种mPCR均具有优异的特异性。对于体外样品,其敏感性为80%至100%,对于临床样品,其敏感性为58%至100%,所获得的结果取决于所用材料和相关基因组区域。 DNA的敏感性通常低于RNA以及整合酶和基质区域的扩增敏感性。就整体检测而言(每种菌株至少有一个靶基因),两种mPCR的体外样品检出率为100%。 M MO2 分别从DNA和RNA中检出100%的临床菌株,而M MO 从这两种材料中均检测到100%的菌株。因此,对于体外和临床样品,M MO2 是检测HIV-1和HIV-2双重感染(称为HIV-1 + HIV)的有用工具-2)和HIV-1 / M + O,以及M MO 可用于检测MO双重感染和MO镶嵌模式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号